Enoxaparin sodium biosimilar (Harvest Moon Pharmaceuticals)

依诺肝素钠生物类似药(Harvest Moon Pharmaceuticals)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEnoxaparin sodium biosimilar (Harvest Moon Pharmaceuticals)
Drug Alias NameEnoxaparinum natricum (Harvest Moon Pharmaceuticals)依诺肝素钠生物仿制药(Harvest Moon Pharmaceuticals)Enoxaparina de sodio (Harvest Moon Pharmaceuticals)
ClassificationBiologics > Biosimilar
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsVenous ThrombosisVenous ThromboembolismMyocardial Infarction +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHarvest Moon
China Registration ClassN/A

Develop Information

Active CompaniesHarvest Moon
Inactive CompaniesN/A
Active IndicationsVenous ThrombosisVenous ThromboembolismMyocardial Infarction +[4
Inactive IndicationsN/A

Other Information

ATC CodeB01AB05
Related LinksN/A